Maziar Mike Doustdar appointed President and CEO of Novo Nordisk
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
Strengthening capabilities in Peptide Therapeutics and CDMO services
Experts urge early detection & better access to care
403 entries from 22 states covering 168 districts highlight groundbreaking initiatives vital to improving national nutrition metrics.
 
        Subscribe To Our Newsletter & Stay Updated